SlideShare a Scribd company logo
Heart Failure with
Preserved Ejection Fraction
Birju Patel, MD MPH
Key points
• Relatively recent term, HFPEF = clinical dx of CHF +
preserved EF
• Half of all CHF, just as lethal
• Characterized by abnormal stiffness (up+left shift of
LV end diastolic pressure-volume relationship –
EDPVR)
• Especially fragile exercise capacity, fatigue, DOE
• Unclear how it happens, comorbidities likely key
• No tx strategy for HFREF has worked in HFPEF
Terminology
Energy
CAD
Structure /
function
Cardiomyopathy
Usually reserved for genetic
pathologies, excluding ischemic,
valvular, hypertensive etiologies
Dilated (eccentric), hypertrophic
(concentric), or restrictive
Congestive heart
failure
syndrome
HFREF
Systolic +/- diastolic
dysfunction
HFPEF
Diastolic but no systolic
dysfunction
Electrical
Arrhythmia
 ~2005
 ICD 9 – 1975
ICD 10 – 1990
pathology
clinical
physiology
clinical
Terminology
Energy
CAD
Structure /
function
Cardiomyopathy
Usually reserved for genetic
pathologies, excluding ischemic,
valvular, hypertensive etiologies
Dilated (eccentric), hypertrophic
(concentric), or restrictive
Congestive heart
failure
syndrome
HFREF
Systolic +/- diastolic
dysfunction
HFPEF
Diastolic but no systolic
dysfunction
Electrical
Arrhythmia
 ~2005
 ICD 9 – 1975
ICD 10 – 1990
pathology
clinical
physiology
clinical
Key point 1A
The term HFPEF is
relatively new
Working definition
• Clinical diagnosis of congestive heart failure
Framingham criteria – 2 major or 1 major + 2 minor
• Ejection fraction normal (>50%)
• No consensus here in US on need for DD or hypertrophy
Major Minor
PND or orthopnea DOE
Rales Nocturnal cough
HJR Tachycardia
S3 Ankle edema
JVD (or elevated CVP) Hepatomegaly
CXR pulmonary edema CXR engorged pulm vessels
Cardiomegaly Pleural effusion
10lb weight loss with diuretics Decreased vital capacity
HPI
PE
Imaging
Empiric!
HPI
Working definition
• Clinical diagnosis of congestive heart failure
Framingham criteria – 2 major or 1 major + 2 minor
• Ejection fraction normal (>50%)
• No consensus here in US on need for DD or hypertrophy
Major Minor
PND or orthopnea DOE
Rales Nocturnal cough
HJR Tachycardia
S3 Ankle edema
JVD (or elevated CVP) Hepatomegaly
CXR pulmonary edema CXR engorged pulm vessels
Cardiomegaly Pleural effusion
10lb weight loss with diuretics Decreased vital capacity
PE
Imaging
Empiric!
Key point 1B
HFPEF = CHF + EF>50
Epidemiology
Prevalence, hospitalizations, mortality
Increasing proportion of HFPEF
Owan TE et al. N Engl J Med 2006;355:251-259.
Increasing proportion of HFPEF
Key point 2A
Half of all CHF is HFPEF
Owan TE et al. N Engl J Med 2006;355:251-259.
Admissions for HFPEF vs HFREF
¼ of CHF discharges
are readmitted
within 30d
Mortality is high
post-discharge
Owan TE et al. N Engl J Med 2006;355:251-259.
Significant mortality in HFPEF
Mean age 74, significant comorbidities including CAD, DM, HTN
Owan TE et al. N Engl J Med 2006;355:251-259.
Significant mortality in HFPEF
Key point 2B
Significant mortality!
Owan TE et al. N Engl J Med 2006;355:251-259.
Mean age 74, significant comorbidities including CAD, DM, HTN
Pathophysiology and
management
Physiologic definition
• Elevated LVEDP (filling pressure)
• Especially during exacerbation or exertion
• Increased stiffness (LV EDPVR)
Systolic dysfunction
Impaired contractility
Diastolic dysfunction
Impaired relaxation
Higher LVEDP
Burkhoff. Heart Failure With a Normal Ejection Fraction: Is It Really a Disorder of Diastolic Function? Circulation. 2003; 107:656-658
Physiologic definition
• Elevated LVEDP (filling pressure)
• Especially during exacerbation or exertion
• Increased stiffness (LV EDPVR)
Systolic dysfunction
Impaired contractility
Burkhoff. Heart Failure With a Normal Ejection Fraction: Is It Really a Disorder of Diastolic Function? Circulation. 2003; 107:656-658
Key point 3
Abnormal stiffness =
up+left shift LV EDPVR
TTE grades of diastolic dysfunction
E – Transmitral doppler of Early passive filling
A – Transmitral doppler of Atrial contraction
e’ – Tissue Doppler of early MV ring
=
Though paradoxically flips with severe DD
E/A
When extreme (>15), may correlate with LVEDP
=E/e’
Normal G1DD G2DD G3/4DD
Nagueh. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Echocardiography. 2008.
Poor exercise tolerance – fatigue
and DOE
• Why does exercise make anyone tired?
• VO2max ~ CO x O2 extraction
• Ventilation/lactate threshold
• Normally CO increases with HR, SV, contractility while
simultaneously decreasing stiffness to improve filling
to match needs
• In HFPEF, HR limits diastolic filling time, stiffness
(EDPVR) paradoxically worsens
Larger LVEDP
necessary,
causes DOE
Limited HR and limited LVEDV
results in non-optimal use of
Frank-Starling curve, reduces
CO (and thus VO2max) and
causes fatigue
Abudiab. Cardiac Output Response to Exercise in Relation to Metabolic Demand in heart Failure with Preserved Ejection Fraction. Eur J Heart Fail. 2013; (15):776-785
Poor exercise tolerance – fatigue
and DOE
• Why does exercise make anyone tired?
• VO2max ~ CO x O2 extraction
• Ventilation/lactate threshold
• Normally CO increases with HR, SV, contractility while
simultaneously decreasing stiffness to improve filling
to match needs
• In HFPEF, HR limits diastolic filling time, stiffness
(EDPVR) paradoxically worsens
Larger LVEDP
necessary,
causes DOE
Limited HR and limited LVEDV
results in non-optimal use of
Frank-Starling curve, reduces
CO (and thus VO2max) and
causes fatigue
Abudiab. Cardiac Output Response to Exercise in Relation to Metabolic Demand in heart Failure with Preserved Ejection Fraction. Eur J Heart Fail. 2013; (15):776-785
Key point 4
People with HFPEF
have poor exercise
tolerance
Pathogenesis
What mediates stiffening / fibrosis? No theory is
definitive, but many acknowledge high burden of
comorbidities
One way to review is to use an anatomic approach to
disease:
• Cardiac
• Interstitial
• Cardiomyocyte
• Non-cardiac
• Vasculature
• Skeletal muscle
Microvascular inflammation
endothelium
cardiomyocyte
interstitial fibrosis
cardiomyocyte stiffening
Paulus. A Novel Paradigm for Heart Failure with Preserved Ejection Fraction. 2013; 62(4)
Inside the cardiomyocyte
Kavita Sharma, and David A. Kass Circulation Research. 2014;115:79-96
Non-cardiac mechanisms
Kavita Sharma, and David A. Kass Circulation Research. 2014;115:79-96
Non-cardiac mechanisms
Key point 5
No definitive
pathogenesis.
Comorbidities likely
key
Does treatment modify outcomes?
Beta blocker
ACEi/ARB
Aldosterone Ant
Digoxin
ISDN/hydralazine
Statin
.5 .75 1 1.5
ORFavors tx Favors control
HFREF
OR
.5 .75 1 1.5
Favors tx
HFPEF
Favors control
Copernicus
Comet
Merit-HF
SOLVD
CHARM Added
CHARM Alt
Val-HEFT
EMPHASIS
EPHESUS
RALES
DIG
A-HeFT
CORONA
GISSI-HF
SENIORS
OPTIMIZE
OPTIMIZE
PEP-CHF
I-PRESERVED
CHARM Preserved
OPTIMIZE
TOPCAT
DIG Ancillary
GISSI-HF
Also, phase 3 for neprilysin
inhibitor pending
Does treatment modify outcomes?
Beta blocker
ACEi/ARB
Aldosterone Ant
Digoxin
ISDN/hydralazine
Statin
.5 .75 1 1.5
ORFavors tx Favors control
HFREF
OR
.5 .75 1 1.5
Favors tx
HFPEF
Favors control
Copernicus
Comet
Merit-HF
SOLVD
CHARM Added
CHARM Alt
Val-HEFT
EMPHASIS
EPHESUS
RALES
DIG
A-HeFT
CORONA
GISSI-HF
SENIORS
OPTIMIZE
OPTIMIZE
PEP-CHF
I-PRESERVED
CHARM Preserved
OPTIMIZE
TOPCAT
DIG Ancillary
GISSI-HF
Key point 6
No treatment
significantly alters
cardiac events in
HFPEF
Key points
• Relatively recent term, HFPEF = clinical dx of CHF +
preserved EF
• Half of all CHF, just as lethal
• Characterized by abnormal stiffness (up+left shift of
LV end diastolic pressure-volume relationship – LV
EDPVR)
• Especially fragile exercise capacity, fatigue, DOE
• Unclear how it happens, comorbidities likely key
• No tx strategy for HFREF has worked in HFPEF

More Related Content

What's hot

Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
Rajat Jain
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEF
Duke Heart
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
ahvc0858
 
ARNI as new standard of care in Heart Failure
ARNI as  new  standard of care in Heart Failure ARNI as  new  standard of care in Heart Failure
ARNI as new standard of care in Heart Failure
SYEDRAZA56411
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021
Duke Heart
 
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
ahvc0858
 
New day in heart failure
New day in heart failureNew day in heart failure
New day in heart failure
Waseem Omar
 
Natural history of Pre tricuspid shunts
Natural history of Pre tricuspid shuntsNatural history of Pre tricuspid shunts
Natural history of Pre tricuspid shunts
drabhishekbabbu
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
Praveen Nagula
 
Management of heart failure with preserved ejection fraction
Management of heart failure with preserved ejection fraction Management of heart failure with preserved ejection fraction
Management of heart failure with preserved ejection fraction
RahulGupta1687
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
Vijay Yadav
 
Assessment of operability of left to right shunts
Assessment of operability of left to right shuntsAssessment of operability of left to right shunts
Assessment of operability of left to right shunts
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Mechanical circulatory support devices
Mechanical circulatory support devicesMechanical circulatory support devices
Mechanical circulatory support devices
RohitWalse2
 
THE EMPEROR-PRESERVED TRIAL ppt.pptx
THE EMPEROR-PRESERVED TRIAL ppt.pptxTHE EMPEROR-PRESERVED TRIAL ppt.pptx
THE EMPEROR-PRESERVED TRIAL ppt.pptx
ddocofdera
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF study
Edgardo Kaplinsky
 
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
PVI, PeerView Institute for Medical Education
 
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxDELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
hospital
 
PROVE HF Study
PROVE HF StudyPROVE HF Study
Artrial fibrillation classification & management guideline
Artrial fibrillation classification & management guidelineArtrial fibrillation classification & management guideline
Artrial fibrillation classification & management guideline
Dr. Rohan Sonawane
 
TAVI
TAVI TAVI

What's hot (20)

Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEF
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 
ARNI as new standard of care in Heart Failure
ARNI as  new  standard of care in Heart Failure ARNI as  new  standard of care in Heart Failure
ARNI as new standard of care in Heart Failure
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021
 
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
 
New day in heart failure
New day in heart failureNew day in heart failure
New day in heart failure
 
Natural history of Pre tricuspid shunts
Natural history of Pre tricuspid shuntsNatural history of Pre tricuspid shunts
Natural history of Pre tricuspid shunts
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Management of heart failure with preserved ejection fraction
Management of heart failure with preserved ejection fraction Management of heart failure with preserved ejection fraction
Management of heart failure with preserved ejection fraction
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Assessment of operability of left to right shunts
Assessment of operability of left to right shuntsAssessment of operability of left to right shunts
Assessment of operability of left to right shunts
 
Mechanical circulatory support devices
Mechanical circulatory support devicesMechanical circulatory support devices
Mechanical circulatory support devices
 
THE EMPEROR-PRESERVED TRIAL ppt.pptx
THE EMPEROR-PRESERVED TRIAL ppt.pptxTHE EMPEROR-PRESERVED TRIAL ppt.pptx
THE EMPEROR-PRESERVED TRIAL ppt.pptx
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF study
 
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap F...
 
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxDELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
 
PROVE HF Study
PROVE HF StudyPROVE HF Study
PROVE HF Study
 
Artrial fibrillation classification & management guideline
Artrial fibrillation classification & management guidelineArtrial fibrillation classification & management guideline
Artrial fibrillation classification & management guideline
 
TAVI
TAVI TAVI
TAVI
 

Viewers also liked

Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
Impact of non cardiac comorbidity on mortality and morbidity in a predominant...Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
drucsamal
 
Hfnef
HfnefHfnef
Dr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
MedPeds Hospitalist
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
Choying Chen
 
Diastolic heart failure
Diastolic heart failureDiastolic heart failure
Diastolic heart failure
Rajeel Imran
 
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
Diastolic dysfunction
Diastolic dysfunctionDiastolic dysfunction
Diastolic dysfunction
Gopan Gopalakrisna Pillai
 

Viewers also liked (8)

Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
Impact of non cardiac comorbidity on mortality and morbidity in a predominant...Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
Impact of non cardiac comorbidity on mortality and morbidity in a predominant...
 
Hfnef
HfnefHfnef
Hfnef
 
Dr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overview
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Management of diastolic heart failure
Management of diastolic heart failureManagement of diastolic heart failure
Management of diastolic heart failure
 
Diastolic heart failure
Diastolic heart failureDiastolic heart failure
Diastolic heart failure
 
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
ECHOCARDIOGRAPHIC EVALUATION of LEFT VENTRICULAR DIASTOLIC FUNCTION toufiqur ...
 
Diastolic dysfunction
Diastolic dysfunctionDiastolic dysfunction
Diastolic dysfunction
 

Similar to Hfpef

cardiologische topics voor huisartsen
cardiologische topics voor huisartsencardiologische topics voor huisartsen
cardiologische topics voor huisartsen
guyodent
 
HFpEF.pptx
HFpEF.pptxHFpEF.pptx
HFpEF.pptx
Izaz Ali Khan
 
Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?
ahvc0858
 
Management of heart failure
Management of heart failureManagement of heart failure
Management of heart failure
Dr-Ajay Tripathi
 
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptxDIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
AbdullahAnsari755347
 
HfpEF Webinar by Dr.P kamath
HfpEF Webinar by Dr.P kamathHfpEF Webinar by Dr.P kamath
HfpEF Webinar by Dr.P kamath
Ramaiah Medical College
 
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptxMANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
JagtishViramuthu
 
Heart Failure Approach class.pptx
Heart Failure Approach class.pptxHeart Failure Approach class.pptx
Heart Failure Approach class.pptx
Best Doctors
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
vaibhavyawalkar
 
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
Brussels Heart Center
 
Heart Failure approach 2022.pdf
Heart Failure approach 2022.pdfHeart Failure approach 2022.pdf
Heart Failure approach 2022.pdf
Best Doctors
 
Anaemia in heart failure
Anaemia in heart failureAnaemia in heart failure
Anaemia in heart failure
drabhishekbabbu
 
11 heart failure
11 heart failure11 heart failure
11 heart failure
internalmed
 
Heart failure – an update
Heart failure – an updateHeart failure – an update
Heart failure – an update
SMSRAZA
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?
drucsamal
 
A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management
Dr.Mahmoud Abbas
 
Atrial Fibrillation in Hypothyroidism
Atrial Fibrillation in HypothyroidismAtrial Fibrillation in Hypothyroidism
Atrial Fibrillation in Hypothyroidism
Stanley Medical College, Department of Medicine
 
Heart failure with preserved ejection fraction dr oday abdow
Heart failure with preserved ejection fraction dr oday abdowHeart failure with preserved ejection fraction dr oday abdow
Heart failure with preserved ejection fraction dr oday abdow
oday abdow
 
Heart failure in elderly
Heart failure in elderlyHeart failure in elderly
Heart failure in elderly
rod prasad
 
Cardiomyopathies & Valvular Disorders - BMH/Tele
Cardiomyopathies & Valvular Disorders - BMH/TeleCardiomyopathies & Valvular Disorders - BMH/Tele
Cardiomyopathies & Valvular Disorders - BMH/Tele
TeleClinEd
 

Similar to Hfpef (20)

cardiologische topics voor huisartsen
cardiologische topics voor huisartsencardiologische topics voor huisartsen
cardiologische topics voor huisartsen
 
HFpEF.pptx
HFpEF.pptxHFpEF.pptx
HFpEF.pptx
 
Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?Heart Failure in Women: More than EF?
Heart Failure in Women: More than EF?
 
Management of heart failure
Management of heart failureManagement of heart failure
Management of heart failure
 
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptxDIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
DIAGNOSIS AND MANAGEMENT OF HEART FAILURE.pptx
 
HfpEF Webinar by Dr.P kamath
HfpEF Webinar by Dr.P kamathHfpEF Webinar by Dr.P kamath
HfpEF Webinar by Dr.P kamath
 
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptxMANAGEMENT OF ATRIAL FIBRILLATION.pptx
MANAGEMENT OF ATRIAL FIBRILLATION.pptx
 
Heart Failure Approach class.pptx
Heart Failure Approach class.pptxHeart Failure Approach class.pptx
Heart Failure Approach class.pptx
 
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
Newer trends in heart failure by Dr. Vaibhav Yawalkar MD DM Cardiology, Consu...
 
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
Insuffisance cardiaque et fibrillation auriculaire - l'oeuf ou la poule (Pr L...
 
Heart Failure approach 2022.pdf
Heart Failure approach 2022.pdfHeart Failure approach 2022.pdf
Heart Failure approach 2022.pdf
 
Anaemia in heart failure
Anaemia in heart failureAnaemia in heart failure
Anaemia in heart failure
 
11 heart failure
11 heart failure11 heart failure
11 heart failure
 
Heart failure – an update
Heart failure – an updateHeart failure – an update
Heart failure – an update
 
Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?Acute Decompensated Heart Failure : What is New ?
Acute Decompensated Heart Failure : What is New ?
 
A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management A New Horizon in Pulmonary Hypertension Management
A New Horizon in Pulmonary Hypertension Management
 
Atrial Fibrillation in Hypothyroidism
Atrial Fibrillation in HypothyroidismAtrial Fibrillation in Hypothyroidism
Atrial Fibrillation in Hypothyroidism
 
Heart failure with preserved ejection fraction dr oday abdow
Heart failure with preserved ejection fraction dr oday abdowHeart failure with preserved ejection fraction dr oday abdow
Heart failure with preserved ejection fraction dr oday abdow
 
Heart failure in elderly
Heart failure in elderlyHeart failure in elderly
Heart failure in elderly
 
Cardiomyopathies & Valvular Disorders - BMH/Tele
Cardiomyopathies & Valvular Disorders - BMH/TeleCardiomyopathies & Valvular Disorders - BMH/Tele
Cardiomyopathies & Valvular Disorders - BMH/Tele
 

More from katejohnpunag

April journal watch
April journal watchApril journal watch
April journal watch
katejohnpunag
 
Ct dip
Ct dipCt dip
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health final
katejohnpunag
 
Depression slides
Depression slidesDepression slides
Depression slides
katejohnpunag
 
Back pain lecture april 22 2015
Back pain lecture april 22 2015Back pain lecture april 22 2015
Back pain lecture april 22 2015
katejohnpunag
 
Back pain lecture april 22 2015
Back pain lecture april 22 2015Back pain lecture april 22 2015
Back pain lecture april 22 2015
katejohnpunag
 
Atypical hus
Atypical hus   Atypical hus
Atypical hus
katejohnpunag
 
Preop pulmonary evaluation 4 16-15
Preop pulmonary evaluation 4 16-15Preop pulmonary evaluation 4 16-15
Preop pulmonary evaluation 4 16-15
katejohnpunag
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15
katejohnpunag
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15
katejohnpunag
 
Cap2015
Cap2015Cap2015
Cap2015
katejohnpunag
 
Resident update talk
Resident update talkResident update talk
Resident update talk
katejohnpunag
 
Complications of cirrhosis review
Complications of cirrhosis reviewComplications of cirrhosis review
Complications of cirrhosis review
katejohnpunag
 
Bayat update talk
Bayat update talkBayat update talk
Bayat update talk
katejohnpunag
 
Peptic ulcer may 2015
Peptic ulcer may 2015Peptic ulcer may 2015
Peptic ulcer may 2015
katejohnpunag
 
March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)
katejohnpunag
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentation
katejohnpunag
 
Res update final
Res update finalRes update final
Res update final
katejohnpunag
 
Resident update talk jtw online
Resident update talk  jtw onlineResident update talk  jtw online
Resident update talk jtw online
katejohnpunag
 
IBD
IBDIBD

More from katejohnpunag (20)

April journal watch
April journal watchApril journal watch
April journal watch
 
Ct dip
Ct dipCt dip
Ct dip
 
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health final
 
Depression slides
Depression slidesDepression slides
Depression slides
 
Back pain lecture april 22 2015
Back pain lecture april 22 2015Back pain lecture april 22 2015
Back pain lecture april 22 2015
 
Back pain lecture april 22 2015
Back pain lecture april 22 2015Back pain lecture april 22 2015
Back pain lecture april 22 2015
 
Atypical hus
Atypical hus   Atypical hus
Atypical hus
 
Preop pulmonary evaluation 4 16-15
Preop pulmonary evaluation 4 16-15Preop pulmonary evaluation 4 16-15
Preop pulmonary evaluation 4 16-15
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15
 
Bowen predm cme.4.9.15
Bowen predm cme.4.9.15Bowen predm cme.4.9.15
Bowen predm cme.4.9.15
 
Cap2015
Cap2015Cap2015
Cap2015
 
Resident update talk
Resident update talkResident update talk
Resident update talk
 
Complications of cirrhosis review
Complications of cirrhosis reviewComplications of cirrhosis review
Complications of cirrhosis review
 
Bayat update talk
Bayat update talkBayat update talk
Bayat update talk
 
Peptic ulcer may 2015
Peptic ulcer may 2015Peptic ulcer may 2015
Peptic ulcer may 2015
 
March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)
 
Final ipf journal club presentation
Final ipf journal club presentationFinal ipf journal club presentation
Final ipf journal club presentation
 
Res update final
Res update finalRes update final
Res update final
 
Resident update talk jtw online
Resident update talk  jtw onlineResident update talk  jtw online
Resident update talk jtw online
 
IBD
IBDIBD
IBD
 

Recently uploaded

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

Hfpef

  • 1. Heart Failure with Preserved Ejection Fraction Birju Patel, MD MPH
  • 2. Key points • Relatively recent term, HFPEF = clinical dx of CHF + preserved EF • Half of all CHF, just as lethal • Characterized by abnormal stiffness (up+left shift of LV end diastolic pressure-volume relationship – EDPVR) • Especially fragile exercise capacity, fatigue, DOE • Unclear how it happens, comorbidities likely key • No tx strategy for HFREF has worked in HFPEF
  • 3. Terminology Energy CAD Structure / function Cardiomyopathy Usually reserved for genetic pathologies, excluding ischemic, valvular, hypertensive etiologies Dilated (eccentric), hypertrophic (concentric), or restrictive Congestive heart failure syndrome HFREF Systolic +/- diastolic dysfunction HFPEF Diastolic but no systolic dysfunction Electrical Arrhythmia  ~2005  ICD 9 – 1975 ICD 10 – 1990 pathology clinical physiology clinical
  • 4. Terminology Energy CAD Structure / function Cardiomyopathy Usually reserved for genetic pathologies, excluding ischemic, valvular, hypertensive etiologies Dilated (eccentric), hypertrophic (concentric), or restrictive Congestive heart failure syndrome HFREF Systolic +/- diastolic dysfunction HFPEF Diastolic but no systolic dysfunction Electrical Arrhythmia  ~2005  ICD 9 – 1975 ICD 10 – 1990 pathology clinical physiology clinical Key point 1A The term HFPEF is relatively new
  • 5. Working definition • Clinical diagnosis of congestive heart failure Framingham criteria – 2 major or 1 major + 2 minor • Ejection fraction normal (>50%) • No consensus here in US on need for DD or hypertrophy Major Minor PND or orthopnea DOE Rales Nocturnal cough HJR Tachycardia S3 Ankle edema JVD (or elevated CVP) Hepatomegaly CXR pulmonary edema CXR engorged pulm vessels Cardiomegaly Pleural effusion 10lb weight loss with diuretics Decreased vital capacity HPI PE Imaging Empiric!
  • 6. HPI Working definition • Clinical diagnosis of congestive heart failure Framingham criteria – 2 major or 1 major + 2 minor • Ejection fraction normal (>50%) • No consensus here in US on need for DD or hypertrophy Major Minor PND or orthopnea DOE Rales Nocturnal cough HJR Tachycardia S3 Ankle edema JVD (or elevated CVP) Hepatomegaly CXR pulmonary edema CXR engorged pulm vessels Cardiomegaly Pleural effusion 10lb weight loss with diuretics Decreased vital capacity PE Imaging Empiric! Key point 1B HFPEF = CHF + EF>50
  • 8. Increasing proportion of HFPEF Owan TE et al. N Engl J Med 2006;355:251-259.
  • 9. Increasing proportion of HFPEF Key point 2A Half of all CHF is HFPEF Owan TE et al. N Engl J Med 2006;355:251-259.
  • 10. Admissions for HFPEF vs HFREF ¼ of CHF discharges are readmitted within 30d Mortality is high post-discharge Owan TE et al. N Engl J Med 2006;355:251-259.
  • 11. Significant mortality in HFPEF Mean age 74, significant comorbidities including CAD, DM, HTN Owan TE et al. N Engl J Med 2006;355:251-259.
  • 12. Significant mortality in HFPEF Key point 2B Significant mortality! Owan TE et al. N Engl J Med 2006;355:251-259. Mean age 74, significant comorbidities including CAD, DM, HTN
  • 14. Physiologic definition • Elevated LVEDP (filling pressure) • Especially during exacerbation or exertion • Increased stiffness (LV EDPVR) Systolic dysfunction Impaired contractility Diastolic dysfunction Impaired relaxation Higher LVEDP Burkhoff. Heart Failure With a Normal Ejection Fraction: Is It Really a Disorder of Diastolic Function? Circulation. 2003; 107:656-658
  • 15. Physiologic definition • Elevated LVEDP (filling pressure) • Especially during exacerbation or exertion • Increased stiffness (LV EDPVR) Systolic dysfunction Impaired contractility Burkhoff. Heart Failure With a Normal Ejection Fraction: Is It Really a Disorder of Diastolic Function? Circulation. 2003; 107:656-658 Key point 3 Abnormal stiffness = up+left shift LV EDPVR
  • 16. TTE grades of diastolic dysfunction E – Transmitral doppler of Early passive filling A – Transmitral doppler of Atrial contraction e’ – Tissue Doppler of early MV ring = Though paradoxically flips with severe DD E/A When extreme (>15), may correlate with LVEDP =E/e’ Normal G1DD G2DD G3/4DD Nagueh. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography. J Echocardiography. 2008.
  • 17. Poor exercise tolerance – fatigue and DOE • Why does exercise make anyone tired? • VO2max ~ CO x O2 extraction • Ventilation/lactate threshold • Normally CO increases with HR, SV, contractility while simultaneously decreasing stiffness to improve filling to match needs • In HFPEF, HR limits diastolic filling time, stiffness (EDPVR) paradoxically worsens Larger LVEDP necessary, causes DOE Limited HR and limited LVEDV results in non-optimal use of Frank-Starling curve, reduces CO (and thus VO2max) and causes fatigue Abudiab. Cardiac Output Response to Exercise in Relation to Metabolic Demand in heart Failure with Preserved Ejection Fraction. Eur J Heart Fail. 2013; (15):776-785
  • 18. Poor exercise tolerance – fatigue and DOE • Why does exercise make anyone tired? • VO2max ~ CO x O2 extraction • Ventilation/lactate threshold • Normally CO increases with HR, SV, contractility while simultaneously decreasing stiffness to improve filling to match needs • In HFPEF, HR limits diastolic filling time, stiffness (EDPVR) paradoxically worsens Larger LVEDP necessary, causes DOE Limited HR and limited LVEDV results in non-optimal use of Frank-Starling curve, reduces CO (and thus VO2max) and causes fatigue Abudiab. Cardiac Output Response to Exercise in Relation to Metabolic Demand in heart Failure with Preserved Ejection Fraction. Eur J Heart Fail. 2013; (15):776-785 Key point 4 People with HFPEF have poor exercise tolerance
  • 19. Pathogenesis What mediates stiffening / fibrosis? No theory is definitive, but many acknowledge high burden of comorbidities One way to review is to use an anatomic approach to disease: • Cardiac • Interstitial • Cardiomyocyte • Non-cardiac • Vasculature • Skeletal muscle
  • 20. Microvascular inflammation endothelium cardiomyocyte interstitial fibrosis cardiomyocyte stiffening Paulus. A Novel Paradigm for Heart Failure with Preserved Ejection Fraction. 2013; 62(4)
  • 21. Inside the cardiomyocyte Kavita Sharma, and David A. Kass Circulation Research. 2014;115:79-96
  • 22. Non-cardiac mechanisms Kavita Sharma, and David A. Kass Circulation Research. 2014;115:79-96
  • 23. Non-cardiac mechanisms Key point 5 No definitive pathogenesis. Comorbidities likely key
  • 24. Does treatment modify outcomes? Beta blocker ACEi/ARB Aldosterone Ant Digoxin ISDN/hydralazine Statin .5 .75 1 1.5 ORFavors tx Favors control HFREF OR .5 .75 1 1.5 Favors tx HFPEF Favors control Copernicus Comet Merit-HF SOLVD CHARM Added CHARM Alt Val-HEFT EMPHASIS EPHESUS RALES DIG A-HeFT CORONA GISSI-HF SENIORS OPTIMIZE OPTIMIZE PEP-CHF I-PRESERVED CHARM Preserved OPTIMIZE TOPCAT DIG Ancillary GISSI-HF Also, phase 3 for neprilysin inhibitor pending
  • 25. Does treatment modify outcomes? Beta blocker ACEi/ARB Aldosterone Ant Digoxin ISDN/hydralazine Statin .5 .75 1 1.5 ORFavors tx Favors control HFREF OR .5 .75 1 1.5 Favors tx HFPEF Favors control Copernicus Comet Merit-HF SOLVD CHARM Added CHARM Alt Val-HEFT EMPHASIS EPHESUS RALES DIG A-HeFT CORONA GISSI-HF SENIORS OPTIMIZE OPTIMIZE PEP-CHF I-PRESERVED CHARM Preserved OPTIMIZE TOPCAT DIG Ancillary GISSI-HF Key point 6 No treatment significantly alters cardiac events in HFPEF
  • 26. Key points • Relatively recent term, HFPEF = clinical dx of CHF + preserved EF • Half of all CHF, just as lethal • Characterized by abnormal stiffness (up+left shift of LV end diastolic pressure-volume relationship – LV EDPVR) • Especially fragile exercise capacity, fatigue, DOE • Unclear how it happens, comorbidities likely key • No tx strategy for HFREF has worked in HFPEF